Title : Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.

Pub. Date : 2008 Jun

PMID : 18368030






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 While urinary L-FABP increased over 100-fold 1 day after cisplatin treatment in the transgenic mice it was significantly reduced when these transgenic mice were pretreated with bezafibrate. Cisplatin fatty acid binding protein 1, liver Mus musculus
2 Immunohistochemical analysis of kidney tissue of bezafibrate-cisplatin-treated transgenic mice showed preservation of cytoplasmic L-FABP in the proximal tubule, but this was reduced in transgenic mice treated only with cisplatin. Cisplatin fatty acid binding protein 1, liver Mus musculus
3 L-FABP mRNA and protein levels were significantly increased in bezafibrate-cisplatin-treated transgenic mice when compared to mice not fibrate treated. Cisplatin fatty acid binding protein 1, liver Mus musculus
4 Our study shows that the bezafibrate-mediated upregulation of proximal tubule L-FABP plays a pivotal role in the reduction of cisplatin-induced acute kidney injury. Cisplatin fatty acid binding protein 1, liver Mus musculus